TP53 and colorectal carcinoma: Dose dependent upregulation of p53-upregulated modulator of apoptosis (PUMA) has been observed in both wild type and p53 knockout cell lines, and is necessary for sunitinib’s pro-apoptotic activity in CRC cells [15].